Nelsilene Mota Carvalho

No ORCID on file · 5 papers in corpus · active 2018-2022

Study types

  • article 4
  • book-chapter 1

Condition tags

  • dysmenorrhea 4
  • endometriosis 4
  • chronic_pelvic_pain 4
book-chapter 2022
AVALIAÇÃO DE BIOMARCADORES EM MULHERES COM ENDOMETRIOSE E DOR USUÁRIAS DO IMPLANTE COM ETONOGESTREL OU SISTEMA INTRAUTERINO COM LEVONORGESTREL: ENSAIO CLÍNICO RANDOMIZADO
·doi:10.53268/bkf22040509

A endometriose é uma doença pélvica benigna e inflamatória, em que há tecido endometrial extrauterino. O tratamento visa reduzir a inflamação. O objetivo deste estudo foi avaliar os escores de dor pélvica crônica, dismenorreia, níveis séric…

article 2020
Endometriosis-associated pain scores and biomarkers in users of the etonogestrel-releasing subdermal implant or the 52-mg levonorgestrel-releasing intrauterine system for up to 24 months
·doi:10.6084/m9.figshare.11866254.v1

Objectives: The aims of the study were to correlate endometriosis-associated pain, evaluated by visual analogue scale (VAS) scores, with serum levels of etonogestrel (ENG), levonorgestrel (LNG), CA-125 and soluble CD23 in users of the ENG i…

article 2020
Endometriosis-associated pain scores and biomarkers in users of the etonogestrel-releasing subdermal implant or the 52-mg levonorgestrel-releasing intrauterine system for up to 24 months
The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception ·doi:10.1080/13625187.2020.1725461

Objectives: The aims of the study were to correlate endometriosis-associated pain, evaluated by visual analogue scale (VAS) scores, with serum levels of etonogestrel (ENG), levonorgestrel (LNG), CA-125 and soluble CD23 in users of the ENG i…

article 2020
Endometriosis-associated pain scores and biomarkers in users of the etonogestrel-releasing subdermal implant or the 52-mg levonorgestrel-releasing intrauterine system for up to 24 months
·doi:10.6084/m9.figshare.11866254

Objectives: The aims of the study were to correlate endometriosis-associated pain, evaluated by visual analogue scale (VAS) scores, with serum levels of etonogestrel (ENG), levonorgestrel (LNG), CA-125 and soluble CD23 in users of the ENG i…

article 2018
Assessment of biomarkers in women with endometriosis-associated pain using the ENG contraceptive implant or the 52 mg LNG-IUS: a non-inferiority randomised clinical trial
The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception ·doi:10.1080/13625187.2018.1531117

OBJECTIVE: The aim of the study was to assess the serum levels of the following biomarkers in women with endometriosis-associated pelvic pain before and after six months of using the etonogestrel (ENG) contraceptive implant or the 52 mg lev…